Loading…

PCN40 Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma: DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma

Saved in:

Bibliographic Details
Published in:	Value in health 2020-12, Vol.23, p.S428-S428
Main Authors:	Mandala, M., Arance, A., Dummer, R., Ascierto, P.A., Gogas, H., Liszkay, G., Garbe, C., Schadendorf, D., Krajsová, I., Gutzmer, R., Chiarion Sileni, V., Dutriaux, C., Loquai, C., Tadmouri, A., Pickard, M.D., Gollerkeri, A., Robert, C., Flaherty, K.T.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!